- Bristol Myers Squibb (Cambridge, MA)
- …state-of-the-art in vitro, in vivo and ex-vivo models of Cancer biology and Immuno -oncology to identify and validate targets. We partner closely with colleagues in ... of relevant experience + Experience and track record in biotherapeutics, immuno -oncology or immunology drug discovery + Good understanding of vascular, stromal,… more
- Bristol Myers Squibb (Cambridge, MA)
- …state-of-the-art in vitro, in vivo and ex-vivo models of Cancer biology and Immuno -oncology to identify and validate targets. We partner closely with colleagues in ... a comprehensive expertise in oncology drug discovery, T cell biology and immuno -oncology. + Industry experience with a proven track record of independently driving… more
- Dana-Farber Cancer Institute (Boston, MA)
- …data sources. + Experience working in **computational immunology** . Human immuno -oncology research in an academic or industry setting analyzing clinical trial ... collaborate across a diverse set of projects within the Center for Immuno -Oncology (CIO), working closely with experts in computational biology, immunology, and… more
- Astellas Pharma (Cambridge, MA)
- …for developing actionable strategies in key therapeutic areas such as immuno -oncology (IO) or tumor-targeted therapies in Oncology. This role integrates deep ... intelligence in a pharmaceutical/biotech environment. + Strong understanding of immuno -oncology, targeted therapies in Oncology, or modality platforms such as… more
- Bristol Myers Squibb (Cambridge, MA)
- …state-of-the-art in vitro, in vivo and ex-vivo models of Cancer biology and Immuno -oncology to identify and validate targets. We partner closely with colleagues in ... Translational Medicine, Informatics and Predictive Sciences and Early Clinical Development to generate biomarker and patient enrichment hypotheses to enable efficient decision making in early clinical trials. We are optimally positioned to complement the… more
- Bristol Myers Squibb (Cambridge, MA)
- …state-of-the-art in vitro, in vivo and ex-vivo models of Cancer biology and Immuno -oncology to identify and validate targets. We partner closely with colleagues in ... Translational Medicine, Informatics and Predictive Sciences and Early Clinical Development to generate biomarker and patient enrichment hypotheses to enable efficient decision making in early clinical trials. We are optimally positioned to complement the… more
- Bio-Techne (MA)
- …to academia segments, across a wide range of applications including immuno -oncology/neurosciences/immunology + Previous experience in Spatial Biology industry is a ... strong plus + Knowledge of in-situ techniques including immunohistochemistry, immunofluorescence, in-situ hybridization, spatial transcriptomics, and similar tissue-based assays is a strong plus + Strong communication and presentation skills + Entrepreneurial… more
- Merck (Boston, MA)
- …Skills:** + Experience with Gynecologic Cancers and/or immuno -oncology \#eligibleforERP **Required Skills:** Accountability, Accountability, Adaptability, Advisory ... Board Development, Anatomic Pathology, Biomarker Development, Business Communications, Clinical Development, Communication, Consultative Approach, Data Analysis, Decision Making, Healthcare Education, Immunochemistry, Immunology, Leadership, Medical Affairs,… more
- Merck (Boston, MA)
- …health care provider for administration to the patient in combination with our immuno -oncology product. This role will also drive the strategy to develop the ... treatment site network and site readiness for the launch of intismeran autogene. This position will report to the **Executive Director, US Oncology Marketing, Intismeran Autogene/Alliance** **Lead** and work cross-functionally with multiple teams across the… more
- Bristol Myers Squibb (Cambridge, MA)
- …careers.bms.com/working-with-us . Bristol Myers Squibb has pioneered the development of immuno -oncology therapies and continues to diversify in drug development for ... the treatment of cancers. Our world-class Translational Development organization is exploring new aspects of tumor and immune biology to create tailored, individualized treatment strategies that will offer the greatest possible benefit to patients. We are… more